181 related articles for article (PubMed ID: 23342018)
1. Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.
Sapkota Y; Ghosh S; Lai R; Coe BP; Cass CE; Yasui Y; Mackey JR; Damaraju S
PLoS One; 2013; 8(1):e53850. PubMed ID: 23342018
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arrays.
Ha G; Shah S
Methods Mol Biol; 2013; 973():355-72. PubMed ID: 23412801
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.
Jung SH; Shin SH; Yim SH; Choi HS; Lee SH; Chung YJ
Exp Mol Med; 2009 Jul; 41(7):462-70. PubMed ID: 19322034
[TBL] [Abstract][Full Text] [Related]
4. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
[TBL] [Abstract][Full Text] [Related]
5. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
[TBL] [Abstract][Full Text] [Related]
6. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
Hawthorn L; Luce J; Stein L; Rothschild J
BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
9. Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer.
Hwang KT; Han W; Cho J; Lee JW; Ko E; Kim EK; Jung SY; Jeong EM; Bae JY; Kang JJ; Yang SJ; Kim SW; Noh DY
Int J Cancer; 2008 Oct; 123(8):1807-15. PubMed ID: 18649361
[TBL] [Abstract][Full Text] [Related]
10. Short somatic alterations at the site of copy number variation in breast cancer.
Murakami F; Tsuboi Y; Takahashi Y; Horimoto Y; Mogushi K; Ito T; Emi M; Matsubara D; Shibata T; Saito M; Murakami Y
Cancer Sci; 2021 Jan; 112(1):444-453. PubMed ID: 32860329
[TBL] [Abstract][Full Text] [Related]
11. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
12. Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group.
Vujkovic M; Attiyeh EF; Ries RE; Horn M; Goodman EK; Ding Y; Kavcic M; Alonzo TA; Gerbing RB; Hirsch B; Raimondi S; Gamis AS; Meshinchi S; Aplenc R
Cancer Genet; 2015; 208(7-8):408-13. PubMed ID: 26163103
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis.
Frankel A; Armour N; Nancarrow D; Krause L; Hayward N; Lampe G; Smithers BM; Barbour A
Genes Chromosomes Cancer; 2014 Apr; 53(4):324-38. PubMed ID: 24446147
[TBL] [Abstract][Full Text] [Related]
14. Germline copy number variations are associated with breast cancer risk and prognosis.
Kumaran M; Cass CE; Graham K; Mackey JR; Hubaux R; Lam W; Yasui Y; Damaraju S
Sci Rep; 2017 Nov; 7(1):14621. PubMed ID: 29116104
[TBL] [Abstract][Full Text] [Related]
15. Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.
Lupicki K; Elifio-Esposito S; Fonseca AS; Weber SH; Sugita B; Langa BC; Pereira SRF; Govender D; Panieri E; Hiss DC; Abdul-Rasool S; Cavalli LR
Int J Oncol; 2018 Dec; 53(6):2745-2757. PubMed ID: 30320392
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
Ching HC; Naidu R; Seong MK; Har YC; Taib NA
Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
[TBL] [Abstract][Full Text] [Related]
18. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Curtis C; Shah SP; Chin SF; Turashvili G; Rueda OM; Dunning MJ; Speed D; Lynch AG; Samarajiwa S; Yuan Y; Gräf S; Ha G; Haffari G; Bashashati A; Russell R; McKinney S; ; Langerød A; Green A; Provenzano E; Wishart G; Pinder S; Watson P; Markowetz F; Murphy L; Ellis I; Purushotham A; Børresen-Dale AL; Brenton JD; Tavaré S; Caldas C; Aparicio S
Nature; 2012 Apr; 486(7403):346-52. PubMed ID: 22522925
[TBL] [Abstract][Full Text] [Related]
19. Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.
Fang M; Toher J; Morgan M; Davison J; Tannenbaum S; Claffey K
Cancer; 2011 May; 117(10):2024-34. PubMed ID: 21523713
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence.
Jones RA; Moorehead RA
Genes Chromosomes Cancer; 2019 Jun; 58(6):381-391. PubMed ID: 30597648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
